<DOC>
	<DOCNO>NCT00815399</DOCNO>
	<brief_summary>Type 2 diabetes epidemic . Its long-term consequence translate enormous human suffer economic cost ; however , much morbidity associate long-term microvascular neuropathic complication substantially reduce intervention achieve glucose level close nondiabetic range . However , none recent intervention study demonstrate benefit intensive glycemic control primary CVD outcome . The investigator report finding long-term randomized comparator-controlled clinical trial conduct patient newly-diagnosed type 2 diabetes . The investigator compare effect pioglitazone metformin circulate endothelial cell-derived submicroscopic membranous vesicle , term microparticles : putative role inflammatory process ability directly affect endothelial function , gain increase popularity surrogate marker cardiovascular outlook . Metformin choose comparator American Diabetes Association recommendation suggest start therapy newly-diagnosed type 2 diabetic subject combine drug ( metformin ) lifestyle change . Moreover , mechanism action pioglitazone distinct metformin .</brief_summary>
	<brief_title>Pioglitazone Versus Metformin Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Men woman age 3075 year , newlydiagnosed type 2 diabetes ( accord ADA criterion ) never treat antihyperglycemic drug , select study . Inclusion criterion also include body mass index ( BMI ) &gt; 25 kg/m2 , HbA1c level &lt; 10 % . Pregnancy breastfeed Any investigational drug within previous 3 month Use agent affect glycemic control ( systemic glucocorticoid , weightloss drug ) Presence clinically relevant somatic mental disease anticipate poor adherence diet regimens To minimize likelihood include subject lateonset type 1 diabetes , candidate positive test antiGAD antibody fast plasma Cpeptide le 0.76 ng/L ( &lt; 0.25 pmol/L ) exclude Also exclude patient abnormal laboratory test , include liver enzyme ( alanine aminotransferase , aspartate aminotransferase , alkaline phosphatase ) great 3 time upper limit normal , serum creatinine great 123.8 Î¼mol/L ( 1.4 mg/dL ) .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>